Welcome to LookChem.com Sign In|Join Free
  • or
1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde is a complex organic chemical compound featuring a pyrazolo-pyridine core, with a tetrahydro-2H-pyran-2-yl group and a dioxaborolan-2-yl group attached to it. As a carbaldehyde, it contains an aldehyde functional group, which makes it a versatile building block in organic synthesis and medicinal chemistry for creating pharmaceuticals and bioactive compounds.

1314734-68-3

Post Buying Request

1314734-68-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1314734-68-3 Usage

Uses

Used in Pharmaceutical Synthesis:
1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde is used as a key intermediate for the synthesis of various pharmaceuticals due to its unique structure and functional groups. The presence of the aldehyde group allows for further reactions and modifications to create a wide range of bioactive molecules.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde is used as a valuable building block for constructing complex organic molecules. Its diverse functional groups enable chemists to perform multiple reactions, leading to the formation of a variety of compounds with potential applications in different industries.
Used in the Suzuki-Miyaura Coupling Reaction:
The dioxaborolan-2-yl group in 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde makes it an ideal reagent for the Suzuki-Miyaura coupling reaction, a widely used method for forming carbon-carbon bonds in organic synthesis. This reaction is particularly important in the development of new pharmaceuticals and advanced materials.
Used in Medicinal Chemistry Research:
In the realm of medicinal chemistry, 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde is used as a starting material for the development of new drugs and therapeutic agents. Its unique structure and functional groups provide a solid foundation for the design and synthesis of novel bioactive molecules with potential applications in treating various diseases and medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 1314734-68-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,7,3 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1314734-68:
(9*1)+(8*3)+(7*1)+(6*4)+(5*7)+(4*3)+(3*4)+(2*6)+(1*8)=143
143 % 10 = 3
So 1314734-68-3 is a valid CAS Registry Number.

1314734-68-3Downstream Products

1314734-68-3Relevant academic research and scientific papers

3-(1H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINE AND THERAPEUTIC USES THEREOF

-

, (2016/06/01)

Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

3-(3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINE AND THERAPEUTIC USES THEREOF

-

, (2016/04/20)

Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1314734-68-3